Current and Emerging Treatments for Myelodysplastic Syndromes: The 2021 Landscape
 | Current and Emerging Treatments for Myelodysplastic Syndromes: The 2021 Landscape CME, CPE, CNE Mikkael A. Sekeres, MD, MS, and Amy E. DeZern, MD, MHS | |
| Release Date: October 25, 2021 Expiration Date: October 25, 2022 | ||
Historically, there have been few effective treatment options for MDS, creating a critical unmet need for therapies. New agents approved in 2020 represent the first new options for MDS in the last several years. Additional novel agents are on the horizon which hold promise to impact the current treatment paradigm.
| ||
| View Only, No Credit | ||